20 February 2023 in Nature Communications
Lipidomics encompassing automated lipid extraction, a four-dimensional (4D) feature selection strategy for confident lipid annotation as well as reproducible and cross-validated quantification can expedite clinical profiling. Here, we determine 4D descriptors (mass to charge, retention time, collision cross section, and fragmentation spectra) of 200 lipid standards and 493 lipids from reference plasma via trapped ion mobility mass spectrometry to enable the implementation of stringent criteria for lipid annotation. We use 4D lipidomics to confidently annotate 370 lipids in reference plasma samples and 364 lipids in serum samples, and reproducibly quantify 359 lipids using level-3 internal standards. We show the utility of our 4D lipidomics workflow for high-throughput applications by reliable profiling of intra-individual lipidome phenotypes in plasma, serum, whole blood, venous and finger-prick dried blood spots.
15 October 2025 in European Heart Journal - Digital Health
Aims: Automatic echocardiographic measurements using artificial intelligence have shown promising results; however, they have not been compared with manual measurements regarding heart failure (HF) progression and algorithm runtime. Methods and results: Data came from the prospective HF study MyoVasc (NCT04064450), which involved a highly standardized 5-h examination, including comprehensive echocardiography, at a dedicated study centre between January 2013 and April 2018. Worsening of HF was a primary composite endpoint, recorded by structured follow-up, death certificates, and medical records. The automated assessment was performed using EchoDL, eight 3D convolutional neural networks (CNNs) trained to predict clinical parameters. Manual and automatic left ventricular ejection fraction (LVEF), E/E′-ratio and left ventricular mass (LVM) demonstrated a good intraclass correlation coefficient {LVEF: 0.75 [95% confidence interval (CI) 0.75–0.77], E/E′-ratio: 0.59 [CI 0.56–0.61], LVM: 0.64 [CI 0.62–0.66]}. After a median follow-up of 3.8 years (IQR 2.1–5.0), 470 patients experienced worsening of HF. In multivariable Cox analysis, comparison of manually and automatically assessed LVEF, E/E′-ratio and LVM demonstrated risk estimates slightly in favour of the CNNs. Direct comparison of C-indices showed significantly better model performance for automatically determined LVEF (0.71 vs. 0.73, P = 0.038) and E/E′-ratio (0.64 vs. 0.66, P = 0.013) and a trend for LVM (0.66 vs. 0.68, P = 0.063). Echo-DL required an average of 1053.4 ms (95% CI 1050.7–1056.0) to analyse a four-second-long echocardiogram. Conclusion: Automated analysis of echocardiograms using 3D CNNs was comparable to manual measurements in predicting HF-specific outcomes. Echo-DL offers potential time savings and improved risk prediction in clinical settings, allowing integration into echocardiographic hardware.